Pain: Clinical Trials

240 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

240 terminated. 240 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4240Terminated 240

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 240 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery
High-dose anrikefon, Medium-dose anrikefon, Low-dose anrikefon - Laparoscopic Surgery, Visceral Pain, Postoperative
Phase 4TerminatedPeking University First Hospital132025-12-252026-04-09
Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control
Placebo, Paracetamol - Pain
Phase 4TerminatedInsel Gruppe AG, University Hospital Bern72024-08-282026-04-13
Ketamine-assisted Therapy for Advanced GI Cancer
Ketamine, Ketamine Injectable Product, Meaning and Purpose therapy - Pancreatic Ductal Adenocarcinoma, Pain, Acute
Phase 4TerminatedBrian Anderson, MD12024-05-172025-05-21
Search to Advance Limited Use of Opioids Pilot: Optimization of Non-Opioid Therapy With a Steroid
Dexamethasone 8mg, Placebo - Pain Management
Phase 4TerminatedRutgers, The State University of New Jersey82023-11-272025-06-04
Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone
Physiotherapy alone, Glenohumeral injection of 40mg (1cc) of Triamcinolone and 7cc of 0.5% Bupivacaine coupled with physiotherapy - Shoulder Pain
Phase 4TerminatedClaire Bourgeois502023-05-212026-03-25
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release - Post Operative Pain, Osteoarthritis, Knee
Phase 4TerminatedBaptist Health South Florida292023-03-092026-05-28
Pregabalin for Central Sensitization in TKA
Pregabalin 75mg - Osteo Arthritis Knee, Central Nervous System Sensitization
Phase 4TerminatedUniversity of Iowa202023-02-212025-03-04
Comparing Local Anesthesia With and Without iPACK Block
Real iPACK block (20 mL of 0.25% bupivacaine, 2.5mcg/mL epinephrine, and 50mcg/mL preservative-free dexamethasone), Sham iPACK block with 20ml normal saline - Osteo Arthritis Knee, Analgesia
Phase 4TerminatedUniversity of Calgary102022-10-302026-06-01
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
BUP microdose induction, TAU, Linkage to outpatient BUP treatment - Substance Use Disorders, Opioid-use Disorder
Phase 4TerminatedMontefiore Medical Center232022-09-292026-05-08
Sternotomies and PectoIntercostal Fascia Blocks in Fast-Track Cardiac Anesthesiology
Pectointercostal fascia blocks, Placebo - Post-operative Pain
Phase 4TerminatedUniversity of Alberta12022-09-222023-12-18
Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations
Liposomal bupivacaine, Bupivacaine Hydrochloride 0.5 % Injectable Solution - Pain, Postoperative, Amputation
Phase 4TerminatedAurora Quaye112022-08-152026-01-27
Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain
Nimbus Sacroiliac Joint Radiofrequency Ablation (N-SIJRFA), Conventional Sacroiliac Joint Radiofrequency Ablation (C-SIJRFA) - Sacroiliac Joint Complex, Low Back Pain
Phase 4TerminatedUniversity of Utah202022-08-152026-06-26
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED
low dose ketamine, Placebo (saline) - Acute Pain, Opioid Use
Phase 4TerminatedUniversity of Aarhus1162022-05-312023-09-26
Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery
N1539 - Post Operative Pain
Phase 4TerminatedBaudax Bio192022-02-242023-09-13
TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery
Liposomal bupivacaine (LB), Dexamethasone and methylprednisolone (CG), Control group (Bupivacaine)- (BPG) - Opioid Use, Pain, Acute
Phase 4TerminatedYale University1472022-02-012025-03-21
The Effect of Pretreatment With Intravenous Lidocaine for Intravenous Contrast:
Preservative Free Lidocaine, Saline - Pain
Phase 4TerminatedAntonios Likourezos32022-01-032025-05-18
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
NSAID capsules, Opioid capsule - Pain, Postoperative, Osteoarthritis Thumb
Phase 4TerminatedStanford University732021-12-272026-10-27
Vital Capacity in Ultrasound Guided Serratus Plane Block in ED Patients With Multiple Rib Fractures
Acetaminophen, Bupivacain, Saline - Pain
Phase 4TerminatedAntonios Likourezos32021-11-012024-06-11
Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study
380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily, 380 mg/300 mg comprimidos metocarbamol/paracetamol - 6 times daily - Low Back Pain
Phase 4TerminatedAziende Chimiche Riunite Angelini Francesco S.p.A1722021-10-072025-01-31
Methadone and Medication Abortion
Methadone Pill, Ibuprofen - Pain, Medical Abortion
Phase 4TerminatedBoston Medical Center42021-10-042023-01-23

Showing 20 of 240. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (66)  ·  Agnosia (23)  ·  Low Back Pain (14)  ·  Acute Pain (13)  ·  Chronic Pain (12)  ·  Back Pain (8)  ·  Headache (7)  ·  Neuralgia (7)  ·  Angina Pectoris (6)  ·  Shoulder Pain (6)  ·  Angina, Stable (5)  ·  Angina, Unstable (5)  ·  Opioid-Related Disorders (5)  ·  Osteoarthritis (5)

Broader conditions

Neurologic Manifestations (240)  ·  Pathological Conditions, Signs and Symptoms (240)  ·  Signs and Symptoms (240)  ·  Pathologic Processes (83)  ·  Postoperative Complications (72)  ·  Nervous System Diseases (54)  ·  Musculoskeletal Diseases (30)  ·  Neurobehavioral Manifestations (26)  ·  Perceptual Disorders (25)  ·  Cardiovascular Diseases (19)  ·  Neuromuscular Diseases (19)  ·  Vascular Diseases (18)  ·  Joint Diseases (17)  ·  Heart Diseases (16)

Interventions

Acetaminophen (24)  ·  Bupivacaine (18)  ·  Sodium Chloride (16)  ·  Dexamethasone (15)  ·  Fentanyl (14)  ·  Morphine (14)  ·  Ropivacaine (12)  ·  Lidocaine (11)  ·  Ketamine (10)  ·  Pregabalin (10)  ·  Gabapentin (9)  ·  Hydromorphone (8)  ·  Ibuprofen (8)  ·  Oxycodone (8)  ·  Saline Solution (6)

Sponsors

Pfizer (8)  ·  University of California, San Diego (6)  ·  Duke University (4)  ·  Montefiore Medical Center (4)  ·  Northwestern University (4)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4)  ·  University of Aarhus (4)  ·  University of Wisconsin, Madison (4)  ·  Wake Forest University Health Sciences (4)  ·  Antonios Likourezos (3)  ·  Boston Scientific Corporation (3)  ·  Cedars-Sinai Medical Center (3)  ·  Massachusetts General Hospital (3)  ·  Pacira Pharmaceuticals, Inc (3)  ·  Rutgers, The State University of New Jersey (3)

Countries

United States (146)  ·  Canada (19)  ·  Denmark (10)  ·  Germany (9)  ·  United Kingdom (9)  ·  France (6)  ·  Italy (6)  ·  Netherlands (5)  ·  South Korea (5)  ·  Switzerland (5)  ·  Spain (4)  ·  Brazil (3)  ·  Hungary (3)  ·  Mexico (3)  ·  Sweden (3)

Top investigators

Brian M Ilfeld, M.D., M.S. (2)  ·  Edmund Volkerts, PhD (2)  ·  Graeme A McLeod, MD FRCA (2)  ·  Jack W Tsao, MD (2)  ·  James C Eisenach, MD (2)  ·  Ole Mathiesen, MD (2)  ·  Roger K Cady, MD (2)  ·  Roya Yumul, MD, PhD (2)  ·  Aaron Fox, MD (1)  ·  Ajay D Wasan, MD, MSc (1)  ·  Albert Losken, MD (1)  ·  Alireza Aminsharifi, M.D. (1)  ·  Allan Struthers, BSc, MD, FRCP, FRSE, FMedSci (1)

Results publications

PMID 1015603, PMID 11331167, PMID 11331334, PMID 11374619, PMID 11472277, PMID 12411815, PMID 12548273, PMID 12560416, PMID 14622770, PMID 16691088, PMID 17138203, PMID 17413915, PMID 18686750, PMID 18762870, PMID 19066382, PMID 19157368, PMID 19174373, PMID 19690943, PMID 20959867, PMID 22020082, PMID 22467891, PMID 22506940, PMID 23061994, PMID 23423135, PMID 23569691, PMID 23709323, PMID 23788067, PMID 23878064, PMID 25135035, PMID 25767411, PMID 2589650, PMID 26185466, PMID 26330019, PMID 26628263, PMID 26759680, PMID 27288381, PMID 27714758, PMID 27782769, PMID 27787895, PMID 28348503, PMID 32527192, PMID 33238043, PMID 37089721, PMID 41475826, PMID 9862240

NIH funding

2008 (4), 2016 (2), 2019 (2), R01NS057594 (2), 1RM1DA055437-01 (1), 2005 (1), 2017 (1), P01GM113852 (1), R01DA036564 (1)